Insights / Experience Fenwick Advises Royalty Pharma in its $525M Royalty Acquisition Agreement with ImmuNext May 16, 2024
Insights / Experience Fenwick Represents Maze Therapeutics in Exclusive Worldwide License Agreement with Shionogi May 15, 2024
Insights / Publication Warner Chappell Warns Infringers: No Time Limit on Damages for Timely Copyright Claims May 10, 2024
Insights / Media Coverage Associate Jennifer Bush Weighs in on the Proposed Changes to PTAB Case Briefing May 10, 2024
